102 related articles for article (PubMed ID: 21166606)
1. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism.
Almqvist EG; Bondeson AG; Bondeson L; Svensson J
Scand J Clin Lab Invest; 2011 Apr; 71(2):139-44. PubMed ID: 21166606
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy.
Almqvist EG; Bondeson AG; Bondeson L; Mellström D; Svensson J
Scand J Clin Lab Invest; 2012 Apr; 72(2):92-9. PubMed ID: 22106852
[TBL] [Abstract][Full Text] [Related]
6. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
Osto E; Fallo F; Pelizzo MR; Maddalozzo A; Sorgato N; Corbetti F; Montisci R; Famoso G; Bellu R; Lüscher TF; Iliceto S; Tona F
Circulation; 2012 Aug; 126(9):1031-9. PubMed ID: 22821942
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic and cardiac dysfunction in primary hyperparathyroidism.
Birgander M; Juul-Möller S; Bondeson AG; Bondeson L; Rydberg E
Clin Endocrinol (Oxf); 2012 Feb; 76(2):189-95. PubMed ID: 21740454
[TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism.
Tassone F; Guarnieri A; Castellano E; Baffoni C; Attanasio R; Borretta G
J Clin Endocrinol Metab; 2015 Aug; 100(8):3069-73. PubMed ID: 26079781
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism.
Emam AA; Mousa SG; Ahmed KY; Al-Azab AA
Med Princ Pract; 2012; 21(3):249-53. PubMed ID: 22179481
[TBL] [Abstract][Full Text] [Related]
10. Endothelial activation markers soluble E-selectin and von Willebrand factor in primary hyperparathyroidism.
Lumachi F; Zanella S; Cella G; Casonato A; Fallo F
In Vivo; 2011; 25(2):279-82. PubMed ID: 21471547
[TBL] [Abstract][Full Text] [Related]
11. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
12. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
Carsello CB; Yen TW; Wang TS
Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study.
Agarwal G; Nanda G; Kapoor A; Singh KR; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Syal SK
Surgery; 2013 Dec; 154(6):1394-403; discussion 1403-4. PubMed ID: 24045156
[TBL] [Abstract][Full Text] [Related]
14. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
15. [Surgical indications of primary hyperparathyroidism].
Tominaga Y
Clin Calcium; 2005 Dec; 15(12):79-84. PubMed ID: 16322678
[TBL] [Abstract][Full Text] [Related]
16. Does renal function improve after parathyroidectomy in primary hyperparathyroidism?
García-Martín F; Guadalix S; García-Boyano F; Melón Peña N; Martínez Pueyo JI; Callejas Martínez R; Praga Terente M
Nefrologia (Engl Ed); 2019; 39(2):160-167. PubMed ID: 30459009
[TBL] [Abstract][Full Text] [Related]
17. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
18. Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism.
Vázquez-Díaz O; Castillo-Martínez L; Orea-Tejeda A; Orozco-Gutiérrez JJ; Asensio-Lafuente E; Reza-Albarrán A; Silva-Tinoco R; Rebollar-González V
Cardiol J; 2009; 16(3):241-5. PubMed ID: 19437398
[TBL] [Abstract][Full Text] [Related]
19. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
